ASEP Medical Holdings Valuation

Is ASEP undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ASEP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate ASEP's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate ASEP's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ASEP?

Key metric: As ASEP is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for ASEP. This is calculated by dividing ASEP's market cap by their current revenue.
What is ASEP's PS Ratio?
PS Ratio	18.2x
Sales	CA$169.12k
Market Cap	CA$4.23m

ASEP key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	82.2x
Enterprise Value/EBITDA	-3.2x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does ASEP's PS Ratio compare to its peers?

The above table shows the PS ratio for ASEP vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	3.9x
SCYB Scryb	3.1x	n/a	CA$4.8m
SQD.H SQI Diagnostics	2x	n/a	CA$6.1m
FREQ Frequency Exchange	10.1x	n/a	CA$8.5m
EVMT Evome Medical Technologies	0.2x	n/a	CA$11.6m
ASEP ASEP Medical Holdings	18.2x	n/a	CA$4.2m

Price-To-Sales vs Peers: ASEP is expensive based on its Price-To-Sales Ratio (18.2x) compared to the peer average (3.9x).

Price to Sales Ratio vs Industry

How does ASEP's PS Ratio compare vs other companies in the CA Medical Equipment Industry?

8 Companies	Price / Sales	Estimated Growth	Market Cap
HTL Hamilton Thorne	3.2x	9.1%	US$247.68m
NSCI Nanalysis Scientific	1x	n/a	US$30.74m
ASG Aurora Spine	1.5x	n/a	US$23.81m
EVMT Evome Medical Technologies	0.2x	n/a	US$8.28m

8 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: ASEP is expensive based on its Price-To-Sales Ratio (18.2x) compared to the North American Medical Equipment industry average (3.2x).

Price to Sales Ratio vs Fair Ratio

What is ASEP's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ASEP PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	18.2x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate ASEP's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

NeuPath Health

CA$9.0m

Provides chronic pain management services in Canada.

NPTH

CA$0.17

6.3%

9.7%

Medical Facilities

CA$369.6m

Through its subsidiaries, owns and operates specialty hospitals and ambulatory surgery center in the United States.

CA$15.55

3.2%

79.1%

Carebook Technologies

CA$6.2m

Engages in the development and commercialization of digital health platforms for assessments, reporting, and targeted solutions in Canada, the United States, Europe, Latin America, Asia, and internationally.

CRBK

CA$0.05

-37.5%

-28.6%